Skip to main content

Table 4 Unadjusted hospital mortality in patient subgroups

From: Glycaemic control in Australia and New Zealand before and after the NICE-SUGAR trial: a translational study

 

Before NICE-SUGAR

After NICE-SUGAR

P

 

n = 82,740

n = 93,765

 

Medical patients*

19.8% (7,569)

18.5% (8,020)

<0.0001

Surgical patients*

5.4% (2,345)

4.91% (2,427)

0.0008

IDDM patients*

13.9% (360)

11.86% (297)

0.029

No-IDDM patients*

12.07% (6,566)

10.93% (6,943)

<0.0001

Patients with >48 h ICU stay*

16.58% (5,489)

15.32% (5,897)

<0.0001

Patients with <48 h ICU stay*

9.06% (4,496)

8.32% (4,596)

<0.0001

  1. *percentage (number of events). NICE-SUGAR, Normoglycemia in Intensive Care Evaluation and Surviving Using Glucose Algorithm Regulation.
Back to article page

Critical Care

ISSN: 1364-8535